BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04895722-completion@plaintrial.com
DTSTAMP:20261028T214007Z
DTSTART;VALUE=DATE:20260813
SUMMARY:Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Ve
 rsus Other Treatments in Participants With Microsatellite Instability-High
  (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (C
 RC) (MK-1308A-008/KEYSTEP-008) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04895722
URL:https://plaintrial.com/trial/NCT04895722
END:VEVENT
END:VCALENDAR